Immune-related lncRNA classification of head and neck squamous cell carcinoma.
Ruoyan CaoLin CuiJiayu ZhangXianyue RenBin ChengJuan XiaPublished in: Cancer cell international (2022)
Our study establishes a novel HNSCC classification on the basis of 31-lncRNA, helping to identify beneficiaries for anti-PD-1 treatment. In addition, a critical lncRNA TRG-AS1 is identified as a new potential prognosis biomarker as well as therapeutic target.